// SECTOR INVESTOR DOSSIER

Investors in Biopharmaceutical

11 investors with active positions in Biopharmaceutical unicorns — combined exposure across this sector $11B in paper valuation.

Note: combined paper valuation reflects overlapping investor positions — individual investors hold stakes in the same companies.